Adage Capital Partners Gp, L.L.C. Revolution Medicines, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51 Billion
- Q1 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 200,000 shares of RVMD stock, worth $7.48 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
200,000Holding current value
$7.48 Million% of portfolio
0.01%Shares
4 transactions
Others Institutions Holding RVMD
# of Institutions
219Shares Held
153MCall Options Held
321KPut Options Held
111K-
Vanguard Group Inc Valley Forge, PA14.8MShares$552 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.7MShares$550 Million0.09% of portfolio
-
Black Rock Inc. New York, NY12.3MShares$460 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY7.55MShares$282 Million3.08% of portfolio
-
Farallon Capital Management LLC San Francisco, CA7.51MShares$281 Million1.13% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.28B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...